World first test potential to identify breast cancer patients who will react badly to radiotherapyApril 19, 2007Medical scientists at the University of Leicester have announced a potentially unique advance in breast cancer research by identifying two genes associated with adverse reaction to cancer treatment. The research could mean people who might react badly to radiotherapy could be warned in advance or alternative treatments be sought. There is no test at present for an abnormal reaction to radiotherapy. No-one in the past has proposed such a test. The team who carried out the study included Drs Paul Symonds, Mark Plumb, Irene Peat and George Giotopoulos of the Department of Cancer Studies and Molecular Medicine and the Department of Genetics at the University of Leicester. Their results are published in the British Journal of Cancer. Dr Symonds said: "Radiotherapy is a very important treatment for breast cancer. A small number of people can develop severe side effects." "During treatment patients can get redness of the skin which may peel off. Later the breast may shrink (atrophy) and the tissues under the skin may become hard and thickened (fibrosis). Red widened blood vessels can appear in the skin (telangiectasia)." After examining patients at the Glenfield Hospital, Leicester Royal Infirmary and the City Hospital Nottingham, the team at the University of Leicester, funded in part by the Hope Foundation for Cancer Research, has found 2 separate genes strongly associated with either thickening of tissue or red widened blood vessels. "About 8% of women carry the fibrosis gene and have 15 times the risk of developing thickening of the tissues which is often associated with lifelong chronic pain. "The genes we have identified at present have a predictive value of 50-60% for the development of marked fibrosis with breast pain. If we could identify the acute genes that lead to marked redness and peeling of the skin, this could increase the predictive value of the test to almost 100%." Dr Symonds said further work needs to be done as the researchers have not found the genes responsible for redness and peeling of the skin during treatment. "In the future it may be possible to identify people who are going to react badly to radiotherapy. Such patients should only receive radiation treatment if there is no alternative and be warned of an increased risk of fibrosis,\\\ University of Leicester |
|||||||||||||||||||||
| Related Radiotherapy Current Events and Radiotherapy News Articles Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results. Blood vessels might predict prostate cancer behavior A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed? Stereotactic radiotherapy offers noninvasive, effective treatment for frail patients with early-stage lung cancer Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians. Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone. Herbal tonic for radiotherapy Antioxidant extracts of the leaves of the Gingko biloba tree may protect cells from radiation damage, according to a study published in the International Journal of Low Radiation. Exercise reduces fatigue in cancer patients undergoing chemotherapy Supervised exercise programmes that include high and low intense cardiovascular and resistance training can help reduce fatigue in patients with cancer who are undergoing adjuvant chemotherapy or treatment for advanced disease. Although more older women receive breast-conserving therapy, gaps in treatment exist According to a new study published in the October issue of the Journal of the American College of Surgeons, although breast-conserving surgery (BCS), commonly known as lumpectomy, is increasingly being used to treat older women with nonmetastatic invasive breast cancer, there are still significant socioeconomic and geographic disparities in the use of this type of therapy. Prediction model superior to traditional criteria in bladder treatment decision A statistical model can accurately predict which patients will have poor outcomes after bladder surgery and can determine the need for chemotherapy. New Approach for the Treatment of Malignant Brain Tumors Initial chemotherapy alone after surgery is just as successful as initial radiation therapy for patients from whom a very malignant brain tumor (anaplastic glioma) was removed. With this treatment, the patients survive on average > 30 months without a recurrence. Mayo Clinic Researchers Find Few Side Effects from Radiation Treatment Given After Prostate Cancer Surgery The largest single-institution study of its kind has found few complications in prostate cancer patients treated with radiotherapy after surgery to remove the prostate. More Radiotherapy Current Events and Radiotherapy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||